IP Library Patent Application 11289624
Patent Application
App. No. 11/289,624

Topographic genotyping

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/289,624
Abstract

The present invention pertains to a method for topographic genotyping. The method comprises the steps of placing a biological specimen having DNA of a patient under a microscope. Then there is the step of inspecting the biological specimen microscopically with the microscope. Next there is the step of choosing a microscope size target on the biological specimen based on its histopathologic characteristics. Next there is the step of separating the target from the specimen. Then there is the step of obtaining DNA sequences from the target so the DNA sequences can be amplified. Next there is the step of amplifying the DNA sequences. Then there is the step of detecting mutations in the DNA sequences. The present invention pertains to a method for topographic genotyping. The method comprises the steps of separating a section from a specimen of fixative treated tissue. Then there is the step of obtaining DNA sequences from the section. Next there is the step of amplifying the DNA sequences by cyphaling them in a PCR machine, with each cycle heating them to a temperature no greater than 99° C., and then back to a temperature of 55° C. in 5 minutes. Next there is the step of detecting mutations in the DNA sequences. Preferably, the separating step includes the step of cutting one to three 2-6 micron thick histeologic sections from the specimen.

Claims (28)

1 . A method for topographic genotyping comprising the steps of:

placing a biological specimen having DNA of a patient under a microscope;

inspecting the biological specimen microscopically with the microscope;

choosing a microscope sized target on the biological specimen based on its histopathologic characteristics;

separating the target from the specimen;

obtaining DNA sequences from the target so the DNA sequences can be amplified;

amplifying the DNA sequences; and

detecting mutations in the DNA sequences.

2 . A method as described in claim 1 wherein the biological specimens include tissue sections, cytological fluids, filter or cellular specimens.

3 . A method as described in claim 1 wherein the specimen is a tissue section and the separating step includes the steps of slicing the target from the section and placing the target on a glass slide.

4 . A method as described in claim 1 wherein the specimen is a tissue section and the cutting step includes the step of placing the target in a tube.

5 . A method as described in claim 1 wherein the specimen is a filter and the separating step includes the steps of cutting an arc segment from a filter and placing the segment in a tube.

6 . A method as described in claim 1 wherein the obtaining step includes the step of extracting the DNA from the target.

7 . A method as described in claim 6 wherein the extracting step includes the step of placing the target in a lysis buffer.

8 . A method as described in claim 7 wherein after the step of placing the target in a lysis buffer, there is the step of adding phenol chloroform into the lysis buffer with the target.

9 . A method as described in claim 8 wherein after the adding step, there is the step of separating short length fragments of DNA being less than 100 base pairs in length from the target.

10 . A method as described in claim 1 wherein the amplifying step includes the steps of choosing a primer corresponding to a gene of the patient; adding the primer to the DNA sequences; and performing polymerase chain reaction on the DNA sequences with primer.

11 . A method as described in claim 1 wherein the detecting step includes the step of determining the DNA sequence.

12 . A method as described in claim 11 including after the determining step, there is the step of comparing the DNA sequence with known DNA sequences for corresponding DNA regions of the target.

13 . A method as described in claim 1 including after the detecting step, there is the step of establishing whether the DNA sequence is associated with a cancer, and applying a treatment regime to attack the cancer.

14 . A method as described in claim 13 including before the applying step, there is the step of identifying a source in the patient for the cancer.

15 . A method as described in claim 1 including after the detecting step, there is the step of establishing whether the DNA sequence is associated with a condition hazardous to the health of the patient.

16 . A method for topographic genotyping comprising the steps of:

separating a section from a specimen of fixative treated tissue;

obtaining DNA sequences from the section;

amplifying the DNA sequences by cycling them in a PCR machine, with each cycle heating them to a temperature no greater than 99° C., and then back to a temperature of 55° C. in 5 minutes; and

detecting mutations in the DNA sequences.

17 . A method as described in claim 16 wherein the separating step includes the step of cutting one to three 2-6 micron thick histologic sections from the specimen.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042858/0971 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS GROUP, INC.; INTERPACE DIAGNOSTICS, LLC; INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042856/0799 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042856/0895 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS GROUP, INC.; INTERPACE BIOPHARMA, LLC; INTERPACE DIAGNOSTICS, LLC; INTERPACE DIAGNOSTICS LAB, INC.; INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042840/0860 →
RELEASE OF SECURITY INTEREST Recorded Feb 22, 2016
From: SWK FUNDING LLC
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 037783/0678 →
SECURITY INTEREST Recorded Nov 18, 2014
From: INTERPACE DIAGNOSTICS CORPORATION
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 034202/0192 →
MERGER AND CHANGE OF NAME Recorded Nov 6, 2014
From: REDPATH INTEGRATED PATHOLOGY, INC.; REDPATH ACQUISITION SUB, INC.; INTERPACE DIAGNOSTICS CORPORATION
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 034114/0658 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: SQUARE 1 BANK
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 034083/0625 →
SECURITY AGREEMENT Recorded Oct 13, 2009
From: REDPATH INTEGRATED PATHOLOGY, INC.
To: SQUARE 1 BANK
Reel/Frame 023364/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2006
From: FINKELSTEIN, SYDNEY DAVID; FINKELSTEIN, PATRICIA ANNE
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 018207/0838 →